Press Releases

Help Help
12/12/2005 ALIZYME ANNOUNCES PRELIMINARY RESULTS FROM ITS SUCCESSFUL PHASE IIb CLINICAL TRIAL OF CETILISTAT IN OBESE DIABETICS HTML Version
22/11/2005 PATIENT RECRUITMENT COMPLETED FOR PHASE IIa CLINICAL TRIAL OF ATL-104 FOR MUCOSITIS HTML Version
09/11/2005 ALIZYME SUCCESSFULLY COMPLETES CLINICAL TRIAL FOR CETILISTAT IN THE USA HTML Version
10/10/2005 ALIZYME PLC APPOINTS PIPER JAFFRAY AS FINANCIAL ADVISOR AND BROKER HTML Version
26/09/2005 ALIZYME GRANTED AUTHORISATION FOR PHASE IIb CLINICAL TRIAL OF ATL-962 IN OBESE DIABETICS HTML Version
19/09/2005 INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2005 pdf (626k)
15/09/2005 WEB CAST NOTIFICATION HTML Version
03/08/2005 INTERIM RESULTS NOTIFICATION FOR THE SIX MONTHS ENDED 30 JUNE 2005 HTML Version
02/08/2005 RECRUITMENT COMPLETED FOR PHASE I CLINICAL TRIAL OF CETILISTAT IN OBESE VOLUNTEERS IN THE USA HTML Version
14/07/2005 PATIENT RECRUITMENT COMPLETED FOR PHASE IIb CLINICAL TRIAL PATIENT RECRUITMENT COMPLETED FOR PHASE IIb CLINICAL TRIAL HTML Version
07/07/2005 ALIZYME REACHES AGREEMENT WITH FDA FOR RENZAPRIDE PHASE III CLINICAL TRIAL HTML Version
30/06/2005 STATEMENT ON RECENT SHARE PRICE MOVEMENT HTML Version
27/05/2005 2004 ANNUAL REPORT AND ACCOUNTS AND AGM NOTIFICATION HTML Version
26/05/2005 ALIZYME SUCCESSFULLY COMPLETES STAGE ONE OF PHASE IIa CLINICAL TRIAL EVALUATING ATL-104 FOR MUCOSITIS HTML Version
18/05/2005 DIRECTORS' SHARE INTERESTS HTML Version
16/05/2005 RESULTS OF PLACING, US PRIVATE PLACEMENT TO QUINTILES AND OPEN OFFER AND EGM HTML Version
21/04/2005 PLACING, US PRIVATE PLACEMENT TO QUINTILES AND OPEN OFFER TO RAISE £32.8 MILLION HTML Version
21/04/2005 ALIZYME SUCCESSFULLY COMPLETES 'THOROUGH CARDIOVASCULAR SAFETY' CLINICAL TRIAL FOR RENZAPRIDE HTML Version
21/04/2005 PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DECEMBER 2004 pdf (174k)
18/03/2005 ALIZYME ACQUIRES PATENT AND INTELLECTUAL PROPERTY RIGHTS TO COLAL® DRUG DELIVERY TECHNOLOGY FROM BTG HTML Version
15/03/2005 ALIZYME OBTAINS APPROVAL FOR A EUROPEAN PHASE III CLINICAL TRIAL OF COLAL-PRED® FOR THE TREATMENT OF ULCERATIVE COLITIS HTML Version
31/01/2005 ALIZYME OPENS INVESTIGATIONAL NEW DRUG APPLICATION FOR CLINICAL TRIAL OF ATL-962 IN USA HTML Version